Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat for overweight adults with type 2 diabetes and constipation
IRCT20191106045356N15Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in constipation and type 2 diabetes mellitus (T2DM) comparing Orlistat with Placebo (2 arms). Primary endpoints: Fasting blood sugar, 2-hour postprandial plasma glucose and 5 more. Started Feb 2023; status: completed.
02
Drugs
orlistat
03
Conditions
constipationtype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20191106045356N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191106045356N15.